JACLYN ABRAHALL: Open Payments
NPI 1972036333 · HAUPPAUGE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,324 in 57 payments from 19 companies in 2025. Trend: 2023 $785 · 2024 $1,340 · 2025 $1,324
Food & beverage: $1,324
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 13 | $271 |
| Novo Nordisk Inc | 8 | $170 |
| SANOFI-AVENTIS U.S. LLC | 4 | $124 |
| Lilly USA, LLC | 5 | $114 |
| Amneal Pharmaceuticals LLC | 4 | $99 |
| Tandem Diabetes Care, Inc. | 5 | $92 |
| Antares Pharma, Inc. | 2 | $66 |
| Madrigal Pharmaceuticals | 2 | $65 |
| Amgen Inc. | 2 | $50 |
| Radius Health, Inc. | 2 | $44 |
Products named: RECORLEV, TZIELD, Wegovy, GVOKE HYPOPEN, UNITHROID, t:slim X2 Insulin Pump with Control-IQ, XYOSTED, REZDIFFRA.
Industry payments across NY — which companies pay providers there.
